Please login to the form below

Not currently logged in
Email:
Password:

GSK wins OTC rights to Merck & Co statin

GSK and Merck & Co enter into an agreement for US over-the-counter marketing rights for Mevacor

UK-based pharmaceutical company GlaxoSmithKline (GSK) and US-headquartered Merck & Co have entered into an agreement for over-the-counter (OTC) marketing rights for Mevacor (lovastatin). 

Terms of the agreement are confidential but include milestone and royalty payments from GSK to Merck over the exclusive rights.

Mevacor was launched on the US market back in 1987, while the regional patent expired in 2001. The drug posted sales of around USD 20m in FY06.

The FDA will review Merck & Co's new drug application (NDA) for OTC Mevacor 20 mg at a joint meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) on 13 December. A final decision is expected in Q1 2008.

The FDA rejected a similar request in 2005. Merck & Co argued then that OTC Mevacor could help unmedicated patients with moderate risk of heart disease.

JP Garnier, GSK's CEO, said: "OTC Mevacor will be a dynamic new addition to our fast-growing OTC business and is further evidence of GSK's ability to partner in new OTC switch opportunities."

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics